Mayflower Financial Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
Mayflower Financial Advisors, LLC
- $1.3 Billion
- Q2 2024
A detailed history of Mayflower Financial Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mayflower Financial Advisors, LLC holds 729,312 shares of VRTX stock, worth $342 Million. This represents 26.25% of its overall portfolio holdings.
Number of Shares
729,312
Previous 729,139
0.02%
Holding current value
$342 Million
Previous $305 Million
12.16%
% of portfolio
26.25%
Previous 23.91%
Shares
15 transactions
Others Institutions Holding VRTX
# of Institutions
1,707Shares Held
226MCall Options Held
1.2MPut Options Held
1.59M-
Capital World Investors Los Angeles, CA26.7MShares$12.5 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$10.8 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.98 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.49 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...